ABSTRACT
Elucidating the mechanism of action (MoA) of antibacterial natural products is crucial to evaluating their potential as novel antibiotics. Marinopyrroles, pentachloropseudilin, and pentabromopseudilin are densely halogenated, hybrid pyrrole-phenol natural products with potent activity against Gram-positive bacterial pathogens like Staphylococcus aureus. However, the exact way they exert this antibacterial activity has not been established. In this study, we explore their structure-activity relationship, determine their spatial location in bacterial cells, and investigate their MoA. We show that the natural products share a common MoA based on membrane depolarization and dissipation of the proton motive force (PMF) that is essential for cell viability. The compounds show potent protonophore activity but do not appear to destroy the integrity of the cytoplasmic membrane via the formation of larger pores or interfere with the stability of the peptidoglycan sacculus. Thus, our current model for the antibacterial MoA of marinopyrrole, pentachloropseudilin, and pentabromopseudilin stipulates that the acidic compounds insert into the membrane and transport protons inside the cell. This MoA may explain many of the deleterious biological effects in mammalian cells, plants, phytoplankton, viruses, and protozoans that have been reported for these compounds.
Subject(s)
Biological Products , Hydrocarbons, Chlorinated , Animals , Anti-Bacterial Agents/pharmacology , Pyrroles/pharmacology , Microbial Sensitivity Tests , MammalsABSTRACT
To date, 16 members of the ammosamide family of natural products have been discovered, and except for ammosamide D each of these metabolites is characterized by an unusual chlorinated pyrrolo[4,3,2-de]quinoline skeleton. Several ammosamides have been shown to inhibit quinone reductase 2, a flavoenzyme responsible for quelling toxic oxidative species in cells or for killing cancer cells outright. Treatment of the extract from an ammosamide-producing culture (Streptomyces strain CNR-698) with a thiol-based reagent designed to label electrophilic natural products produced an ammosamide C-thiol adduct. This observation led us to hypothesize, and then demonstrate through experimentation, that all of the other ammosamides are derived from ammosamide C via nonenzymatic processes involving exposure to nucleophiles, air, and light. Like many established electrophilic natural products, reaction with the thiol probe suggests that ammosamide C is itself an electrophilic natural product. Although ammosamide C did not show substantial cytotoxicity against cancer cells, its activity against a marine Bacillus bacterial strain may reflect its ecological role.
Subject(s)
Amides/isolation & purification , Amides/pharmacology , Biological Products/isolation & purification , Biological Products/pharmacology , Heterocyclic Compounds, 2-Ring/isolation & purification , Heterocyclic Compounds, 2-Ring/pharmacology , Heterocyclic Compounds, 3-Ring/isolation & purification , Heterocyclic Compounds, 3-Ring/pharmacology , Quinolines/isolation & purification , Quinolines/pharmacology , Streptomyces/drug effects , Sulfhydryl Compounds/pharmacology , Amides/chemistry , Biological Products/chemistry , Heterocyclic Compounds, 2-Ring/chemistry , Heterocyclic Compounds, 3-Ring/chemistry , Humans , Molecular Structure , Quinolines/chemistry , Sulfhydryl Compounds/chemistryABSTRACT
Nematophin, a known antibiotic natural product against Staphylococcus aureus for almost 20 years, is produced by all strains of Xenorhabdus nematophila. Despite its simple structure, its biosynthesis was unknown. Its biosynthetic pathway is reported using heterologous production in Escherichia coli. Additionally, the identification, structure elucidation, and biosynthesis of six extended nematophin derivatives from Xenorhabdus PB62.4 carrying an additional valine are reported. Preliminary bioactivity studies suggest a biological role of these compounds in the bacteria-nematode-insect symbiosis.
Subject(s)
Anti-Bacterial Agents/biosynthesis , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antiparasitic Agents/chemistry , Antiparasitic Agents/metabolism , Antiparasitic Agents/pharmacology , Escherichia coli/metabolism , Indoles/chemistry , Indoles/metabolism , Indoles/pharmacology , Leishmania/drug effects , Myoblasts/drug effects , Myoblasts/parasitology , Nematoda/drug effects , Plasmodium falciparum/drug effects , Rats , Staphylococcus aureus/drug effects , Structure-Activity Relationship , Trypanosoma/drug effects , Xenorhabdus/metabolismABSTRACT
New methods are urgently needed to find novel natural products as structural leads for the development of new drugs against emerging diseases such as cancer and multiresistant bacterial infections. Here we introduce a reactivity-guided drug discovery approach for electrophilic natural products, a therapeutically relevant class of natural products that covalently modify their cellular targets, in crude extracts. Using carefully designed halogenated aromatic reagents, the process furnishes derivatives that are UV-active and highly conspicuous via mass spectrometry by virtue of an isotopically unique bromine or chlorine tag. In addition to the identification of high-value metabolites, the process facilitates the difficult task of structure elucidation by providing derivatives that are primed for X-ray crystallographic analysis. We show that a cysteine probe efficiently and chemoselectively labels enone-, ß-lactam-, and ß-lactone-based electrophilic natural products (parthenolide, andrographolide, wortmannin, penicillin G, salinosporamide), while a thiophenol probe preferentially labels epoxide-based electrophilic natural products (triptolide, epoxomicin, eponemycin, cyclomarin, salinamide). Using the optimized method, we were able to detect and isolate the epoxide-bearing natural product tirandalydigin from Salinispora and thereby link an orphan gene cluster to its gene product.
Subject(s)
Biological Products/chemistry , Molecular Probes/chemistry , Sulfhydryl Compounds/chemistry , Cell Line, Tumor , Crystallography, X-Ray , Humans , Magnetic Resonance SpectroscopyABSTRACT
The biosynthesis gene cluster of the xenortides and a new derivative, xenortide D, which is produced in only trace amounts, was identified in Xenorhabdus nematophila. The structure of xenortide D was elucidated using a combination of labeling experiments followed by MS analysis and was confirmed by synthesis. Bioactivity tests revealed a weak activity of tryptamine-carrying xenortides against Plasmodium falciparum and Trypanosoma brucei.
Subject(s)
Dipeptides/metabolism , Xenorhabdus/chemistry , Chromatography, High Pressure Liquid , Dipeptides/chemistry , Dipeptides/pharmacology , Leishmania/drug effects , Molecular Structure , Multigene Family , Nuclear Magnetic Resonance, Biomolecular , Parasitic Sensitivity Tests , Plasmodium falciparum/drug effects , Trypanosoma brucei brucei/drug effects , Tryptamines/chemistryABSTRACT
Highlight describes the recently discovered prodrug activation mechanism found in the biosynthesis of nonribosomally produced peptides and peptide/polyketide hybrids as well as related mechanisms.
Subject(s)
Bacteria/enzymology , Peptide Synthases/metabolism , Polyketide Synthases/metabolism , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/chemistry , Bacteria/chemistry , Molecular Structure , Peptide Biosynthesis , Prodrugs/chemistry , Prodrugs/metabolismABSTRACT
Six novel linear peptides, named "rhabdopeptides", have been identified in the entomopathogenic bacterium Xenorhabdus nematophila after the discovery of the corresponding rdp gene cluster by using a promoter trap strategy for the detection of insect-inducible genes. The structures of these rhabdopeptides were deduced from labeling experiments combined with detailed MS analysis. Detailed analysis of an rdp mutant revealed that these compounds participate in virulence towards insects and are produced upon bacterial infection of a suitable insect host. Furthermore, two additional rhabdopeptide derivatives produced by Xenorhabdus cabanillasii were isolated, these showed activity against insect hemocytes thereby confirming the virulence of this novel class of compounds.
Subject(s)
Antiprotozoal Agents/metabolism , Manduca/microbiology , Peptides/metabolism , Virulence Factors/metabolism , Xenorhabdus/metabolism , Animals , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/isolation & purification , Antiprotozoal Agents/pharmacology , Peptide Synthases/metabolism , Peptides/chemistry , Peptides/isolation & purification , Peptides/pharmacology , Species Specificity , Virulence Factors/chemistry , Xenorhabdus/physiologyABSTRACT
Structure elucidation of natural products including the absolute configuration is a complex task that involves different analytical methods like mass spectrometry, NMR spectroscopy, and chemical derivation, which are usually performed after the isolation of the compound of interest. Here, a combination of stable isotope labeling of Photorhabdus and Xenorhabdus strains and their transaminase mutants followed by detailed MS analysis enabled the structure elucidation of novel cyclopeptides named GameXPeptides including their absolute configuration in crude extracts without their actual isolation.
Subject(s)
Biological Products/chemistry , Isotope Labeling/methods , Mass Spectrometry/methods , Peptides, Cyclic/chemistry , Peptides/chemistry , Magnetic Resonance Spectroscopy , StereoisomerismABSTRACT
We have identified a new mechanism for the cleavage and activation of nonribosomally made peptides and peptide-polyketide hybrids that are apparently operational in several different bacteria. This process includes the cleavage of a precursor molecule by a membrane-bound and D-asparagine-specific peptidase, as shown here in the biosynthesis of the antibiotic xenocoumacin from Xenorhabdus nematophila.
Subject(s)
Anti-Bacterial Agents/biosynthesis , Peptide Biosynthesis , Prodrugs/metabolism , Xenorhabdus/chemistry , Anti-Bacterial Agents/chemistry , Benzopyrans/chemistry , Benzopyrans/metabolism , Molecular Conformation , Prodrugs/chemistry , StereoisomerismABSTRACT
Xenocoumacin 1 (Xcn1) and xenocoumacin 2 (Xcn2) are the major antimicrobial compounds produced by Xenorhabdus nematophila. To study the role of Xcn1 and Xcn2 in the life cycle of X. nematophila the 14 gene cluster (xcnA-N) required for their synthesis was identified. Overlap RT-PCR analysis identified six major xcn transcripts. Individual inactivation of the non-ribosomal peptide synthetase genes, xcnA and xcnK, and polyketide synthetase genes, xcnF, xcnH and xcnL, eliminated Xcn1 production. Xcn1 levels and expression of xcnA-L were increased in an ompR strain while Xcn2 levels and xcnMN expression were reduced. Xcn1 production was also increased in a strain lacking acetyl-phosphate that can donate phosphate groups to OmpR. Together these findings suggest that OmpR-phosphate negatively regulates xcnA-L gene expression while positively regulating xcnMN expression. HPLC-MS analysis revealed that Xcn1 was produced first and was subsequently converted to Xcn2. Inactivation of xcnM and xcnN eliminated conversion of Xcn1 to Xcn2 resulting in elevated Xcn1 production. The viability of the xcnM strain was reduced 20-fold relative to the wild-type strain supporting the idea that conversion of Xcn1 to Xcn2 provides a mechanism to avoid self-toxicity. Interestingly, inactivation of ompR enhanced cell viability during prolonged culturing.